UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G*

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2

(Amendment No. __)*

 

 

Calithera Biosciences, Inc.
(Name of Issuer)
 
Common stock, par value $0.0001 per share
(Title of Class of Securities)
 
13089P101
(CUSIP Number)
 
November 10, 2021
(Date of Event Which Requires Filing of the Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 13089P101 13G Page 2 of 13 Pages

 

 

1.

NAME OF REPORTING PERSONS

 

Citadel Advisors LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)     o

(b)     o

 

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

3,493,833 shares

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

See Row 6 above

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

See Row 6 above

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

4.7%1

12.

TYPE OF REPORTING PERSON

 

IA; OO; HC

       

 

 

 

1The percentages reported in this Schedule 13G are based upon 74,926,064 shares of common stock outstanding as of November 4, 2021 (according to the issuer’s Form 10-Q as filed with the Securities and Exchange Commission on November 9, 2021).  Except as described in the preceding sentence, all share numbers for the holdings of the reporting persons reported in this Schedule 13G are as of the opening of the market on November 22, 2021.

 

 

 

CUSIP No. 13089P101 13G Page 3 of 13 Pages

 

 

1.

NAME OF REPORTING PERSONS

 

Citadel Advisors Holdings LP

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)     o

(b)     o

 

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

3,493,833 shares

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

See Row 6 above

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

See Row 6 above

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

4.7%

12.

TYPE OF REPORTING PERSON

 

PN; HC

       

 

 

 

CUSIP No. 13089P101 13G Page 4 of 13 Pages

 

 

1.

NAME OF REPORTING PERSONS

 

Citadel GP LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)     o

(b)     o

 

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

3,493,833 shares

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

See Row 6 above

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

See Row 6 above

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

4.7%

12.

TYPE OF REPORTING PERSON

 

OO; HC

       

 

 

 

CUSIP No. 13089P101 13G Page 5 of 13 Pages

 

 

1.

NAME OF REPORTING PERSONS

 

Citadel Securities LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)     o

(b)     o

 

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

190,310 shares

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

See Row 6 above

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

See Row 6 above

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.3%

12.

TYPE OF REPORTING PERSON

 

BD; OO

       

 

 

 

CUSIP No. 13089P101 13G Page 6 of 13 Pages

 

 

1.

NAME OF REPORTING PERSONS

 

Citadel Securities Group LP

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)     o

(b)     o

 

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

190,310 shares

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

See Row 6 above

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

See Row 6 above

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.3%

12.

TYPE OF REPORTING PERSON

 

PN; HC

       

 

 

 

CUSIP No. 13089P101 13G Page 7 of 13 Pages

 

 

1.

NAME OF REPORTING PERSONS

 

Citadel Securities GP LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)     o

(b)     o

 

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

190,310 shares

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

See Row 6 above

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

See Row 6 above

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

0.3%

12.

TYPE OF REPORTING PERSON

 

OO; HC

       

 

 

 

CUSIP No. 13089P101 13G Page 8 of 13 Pages

 

 

1.

NAME OF REPORTING PERSONS

 

Kenneth Griffin

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)     o

(b)     o

 

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

U.S. Citizen

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5.

SOLE VOTING POWER

 

0

6.

SHARED VOTING POWER

 

3,684,143 shares

7.

SOLE DISPOSITIVE POWER

 

0

8.

SHARED DISPOSITIVE POWER

 

See Row 6 above

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

See Row 6 above

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

o

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

4.9%

12.

TYPE OF REPORTING PERSON

 

IN; HC

       

 

 

 

CUSIP No. 13089P101 13G Page 9 of 13 Pages

 

 

Item 1(a). Name of Issuer:
  Calithera Biosciences, Inc.
   
Item 1(b). Address of Issuer’s Principal Executive Offices:
  343 Oyster Point Blvd., Suite 200, South San Francisco, CA 94080
   
Item 2(a). Name of Person Filing:
 

This Schedule 13G is being jointly filed by Citadel Advisors LLC (“Citadel Advisors”), Citadel Advisors Holdings LP (“CAH”), Citadel GP LLC (“CGP”), Citadel Securities LLC (“Citadel Securities”), Citadel Securities Group LP (“CALC4”), Citadel Securities GP LLC (“CSGP”) and Mr. Kenneth Griffin (collectively with Citadel Advisors, CAH, CGP, Citadel Securities, CALC4 and CSGP, the “Reporting Persons”) with respect to shares of common stock (and options to purchase common stock) of the above-named issuer owned by Citadel Multi-Strategy Equities Master Fund Ltd., a Cayman Islands company (“CM”), and Citadel Securities.

 

Citadel Advisors is the portfolio manager for CM.  CAH is the sole member of Citadel Advisors.  CGP is the general partner of CAH.  CALC4 is the non-member manager of Citadel Securities. CSGP is the general partner of CALC4.  Mr. Griffin is the President and Chief Executive Officer of CGP, and owns a controlling interest in CGP and CSGP.

 

The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any).

   
Item 2(b). Address of Principal Business Office or, if none, Residence:
  The address of the principal business office of each of the Reporting Persons is 131 S. Dearborn Street, 32nd Floor, Chicago, Illinois 60603.
   
Item 2(c). Citizenship:
  Each of Citadel Advisors, CGP, Citadel Securities and CSGP is organized as a limited liability company under the laws of the State of Delaware.  Each of CALC4 and CAH is organized as a limited partnership under the laws of the State of Delaware.  Mr. Griffin is a U.S. citizen.
   
Item 2(d). Title of Class of Securities:
  Common stock, par value $0.0001 per share
   
Item 2(e). CUSIP Number:
  13089P101

 

 

 

CUSIP No. 13089P101 13G Page 10 of 13 Pages

 

 

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
   
  (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
  (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
  (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
  (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
  (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
  (f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
  (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
  (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
  (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
  (k) ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

 

If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________.

 

Item 4.Ownership:

 

A.Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC
   
(a)Each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed to beneficially own 3,493,833 shares of common stock.
   
(b)The number of shares that each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed to beneficially own constitutes approximately 4.7% of the common stock outstanding.
   
(c)Number of shares as to which such person has:
   
(i)sole power to vote or to direct the vote: 0
   
(ii)shared power to vote or to direct the vote: 3,493,833
   
(iii)sole power to dispose or to direct the disposition of: 0
   
(iv)shared power to dispose or to direct the disposition of: 3,493,833

 

 

 

CUSIP No. 13089P101 13G Page 11 of 13 Pages

 

 

B.Citadel Securities LLC

 

(a)Citadel Securities LLC may be deemed to beneficially own 190,310 shares of common stock.
   
(b)The number of shares that Citadel Securities LLC may be deemed to beneficially own constitutes approximately 0.3% of the common stock outstanding.
   
(c)Number of shares as to which such person has:
   
(i)sole power to vote or to direct the vote: 0
   
(ii)shared power to vote or to direct the vote: 190,310
   
(iii)sole power to dispose or to direct the disposition of: 0
   
(iv)shared power to dispose or to direct the disposition of: 190,310

 

C.Citadel Securities Group LP and Citadel Securities GP LLC

 

(a)Each of Citadel Securities Group LP and Citadel Securities GP LLC may be deemed to beneficially own 190,310 shares of common stock.
   
(b)The number of shares that each of Citadel Securities Group LP and Citadel Securities GP LLC may be deemed to beneficially own constitutes approximately 0.3% of the common stock outstanding.
   
(c)Number of shares as to which such person has:
   
(i)sole power to vote or to direct the vote: 0
   
(ii)shared power to vote or to direct the vote: 190,310
   
(iii)sole power to dispose or to direct the disposition of: 0
   
(iv)shared power to dispose or to direct the disposition of: 190,310

 

 

 

CUSIP No. 13089P101 13G Page 12 of 13 Pages

 

 

D.Kenneth Griffin
   
(a)Mr. Griffin may be deemed to beneficially own 3,684,143 shares of common stock.
   
(b)The number of shares that Mr. Griffin may be deemed to beneficially own constitutes approximately 4.9% of the common stock outstanding.
   
(c)Number of shares as to which such person has:
   
(i)sole power to vote or to direct the vote: 0
   
(ii)shared power to vote or to direct the vote: 3,684,143
   
(iii)sole power to dispose or to direct the disposition of: 0
   
(iv)shared power to dispose or to direct the disposition of: 3,684,143

 

Item 5. Ownership of Five Percent or Less of a Class:
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following. ¨
   
Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
  Not Applicable
   
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
  See Item 2 above
   
Item 8. Identification and Classification of Members of the Group:
  Not Applicable
   
Item 9. Notice of Dissolution of Group:
  Not Applicable
   
Item 10. Certifications:
  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

CUSIP No. 13089P101 13G Page 13 of 13 Pages

 

 

SIGNATURE

 

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

 

Dated this 22nd day of November, 2021.

 

CITADEL SECURITIES LLC   CITADEL ADVISORS LLC  
           
By: /s/ Guy Miller   By: /s/ Gregory Johnson  
  Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory  
           
           
CITADEL SECURITIES GROUP LP   CITADEL ADVISORS HOLDINGS LP  
           
By: /s/ Guy Miller   By: /s/ Gregory Johnson  
  Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory  
           
           
CITADEL SECURITIES GP LLC   CITADEL GP LLC  
           
By: /s/ Guy Miller   By: /s/ Gregory Johnson  
  Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory  
           
           
      KENNETH GRIFFIN  
           
      By: /s/ Gregory Johnson  
        Gregory Johnson, attorney-in-fact*  

 

 

 
*

Gregory Johnson is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein.  The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Jaws Acquisitions Corp. on February 1, 2021.

 

 

 

 

EXHIBIT 99.1

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree that the Statement on Schedule 13G filed herewith (and any amendments thereto), relating to the common stock of Calithera Biosciences, Inc., a Delaware corporation, is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934, as amended, on behalf of each of the undersigned.

 

This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.

 

Dated this 22nd day of November, 2021.

 

CITADEL SECURITIES LLC   CITADEL ADVISORS LLC  
           
By: /s/ Guy Miller   By: /s/ Gregory Johnson  
  Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory  
           
           
CITADEL SECURITIES GROUP LP   CITADEL ADVISORS HOLDINGS LP  
           
By: /s/ Guy Miller   By: /s/ Gregory Johnson  
  Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory  
           
           
CITADEL SECURITIES GP LLC   CITADEL GP LLC  
           
By: /s/ Guy Miller   By: /s/ Gregory Johnson  
  Guy Miller, Authorized Signatory     Gregory Johnson, Authorized Signatory  
           
           
      KENNETH GRIFFIN  
           
      By: /s/ Gregory Johnson  
        Gregory Johnson, attorney-in-fact*  

 

 

 
*Gregory Johnson is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein.  The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Jaws Acquisitions Corp. on February 1, 2021.